Osteoporosis in Men

What is Osteoporosis?

Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, leading to increased bone fragility and risk of fractures. While often thought of as a "woman's disease," osteoporosis in men is more common than many realize and often underdiagnosed.

How Common is it in Men?

  • 1 in 4 men over age 50 will have an osteoporotic fracture in their lifetime
  • About 2 million American men have osteoporosis
  • Men have HIGHER mortality rates after hip fractures than women (30-40% die within 1 year)
  • Often diagnosed later than in women because men aren't routinely screened

Causes of Osteoporosis in Men:

Primary Osteoporosis:

  • Age-related bone loss
  • Idiopathic (no identifiable cause)

Secondary Osteoporosis (60% of cases in men):

  • Hypogonadism (Most Common): Low testosterone—from aging, pituitary disorders, medications, or testicular damage
  • Glucocorticoid Use: Prednisone, dexamethasone (most common medication cause)
  • Alcohol Abuse: Excessive intake impairs bone formation
  • Smoking
  • Gastrointestinal Diseases: Celiac disease, IBD, malabsorption
  • Chronic Kidney Disease
  • Hyperthyroidism or Excess Thyroid Hormone
  • Hyperparathyroidism
  • Multiple Myeloma, Lymphoma
  • Rheumatoid Arthritis, Chronic Liver Disease
  • Medications: Anticonvulsants, proton pump inhibitors (long-term), chemotherapy
  • Androgen Deprivation Therapy (ADT) for Prostate Cancer

Risk Factors:

  • Age >70
  • Low body weight (BMI <20)< /li>
  • Previous fracture after age 50
  • Family history of osteoporosis or hip fracture
  • Sedentary lifestyle
  • Low calcium and Vitamin D intake
  • Excessive alcohol or caffeine

Diagnosis:

DEXA Scan (Dual-Energy X-ray Absorptiometry):

  • Measures bone mineral density (BMD) at hip and spine
  • T-score ≤ -2.5: Osteoporosis
  • T-score -1.0 to -2.5: Osteopenia (low bone mass)
  • T-score ≥ -1.0: Normal

Who should be screened?

  • All men age 70 and older
  • Men age 50-69 with risk factors (fracture, low testosterone, steroid use, etc.)
  • Any man with a fragility fracture

Labs (to identify secondary causes):

  • Testosterone (total and free), LH, FSH
  • 25-OH Vitamin D
  • Calcium, phosphorus, alkaline phosphatase
  • TSH, parathyroid hormone (PTH)
  • Complete blood count, liver function, kidney function
  • Celiac screen (tissue transglutaminase antibody)
  • Bone turnover markers (CTX, P1NP)—optional

Treatment:

1. Lifestyle Modifications:

  • Weight-bearing exercise: Walking, jogging, resistance training
  • Quit smoking
  • Limit alcohol (≤2 drinks/day)
  • Fall prevention: Home safety, balance exercises, vision check

2. Calcium and Vitamin D:

  • Calcium: 1200 mg/day (diet + supplement)
  • Vitamin D: 800-2000 IU/day; maintain 25-OH Vitamin D >30 ng/mL

3. Treat Underlying Causes:

  • Testosterone replacement (if hypogonadal)
  • Stop or minimize steroids (if possible)
  • Treat hyperthyroidism, hyperparathyroidism
  • Address alcohol abuse

4. Medications for Osteoporosis:

Bisphosphonates (First-Line):

  • Alendronate (Fosamax®): 70 mg weekly (oral)
  • Risedronate (Actonel®): 35 mg weekly (oral)
  • Zoledronic Acid (Reclast®): 5 mg IV once yearly
  • Reduce fracture risk by 40-70%

Denosumab (Prolia®):

  • Subcutaneous injection every 6 months
  • Very effective; alternative to bisphosphonates

Teriparatide (Forteo®) or Abaloparatide (Tymlos®):

  • Daily subcutaneous injection (parathyroid hormone analogs)
  • Anabolic agents—BUILD new bone
  • Reserved for severe osteoporosis or multiple fractures
  • Used for 1-2 years, then transition to anti-resorptive

Romosozumab (Evenity®):

  • Monthly subcutaneous injection (sclerostin inhibitor)
  • Both builds bone AND reduces breakdown
  • Used for 12 months in very high-risk patients

When to Start Treatment:

  • T-score ≤ -2.5 (osteoporosis)
  • History of hip or vertebral fracture
  • T-score -1.0 to -2.5 (osteopenia) + high FRAX score (10-year hip fracture risk ≥3% or major osteoporotic fracture risk ≥20%)
  • Long-term glucocorticoid use (prednisone ≥5 mg/day for ≥3 months)

Monitoring:

  • DEXA scan every 1-2 years while on treatment
  • Reassess Vitamin D, calcium levels annually
  • Monitor for side effects

Key Points:

  • Osteoporosis in men is UNDERDIAGNOSED and UNDERTREATED
  • Always look for secondary causes (especially low testosterone)
  • Treatment reduces fracture risk significantly
  • Men with hip fractures have worse outcomes than women—early diagnosis and treatment are critical
← Previous Topic Next Topic →